ATE268175T1 - Decursin-enthaltende pharmazeutische zusammensetzungen - Google Patents

Decursin-enthaltende pharmazeutische zusammensetzungen

Info

Publication number
ATE268175T1
ATE268175T1 AT99951229T AT99951229T ATE268175T1 AT E268175 T1 ATE268175 T1 AT E268175T1 AT 99951229 T AT99951229 T AT 99951229T AT 99951229 T AT99951229 T AT 99951229T AT E268175 T1 ATE268175 T1 AT E268175T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
compositions containing
decursin
containing decursin
agent
Prior art date
Application number
AT99951229T
Other languages
English (en)
Inventor
Se Young Chong
Ik Hwan Kim
Kyung Seop Ahn
Sang Ki Kim
Original Assignee
Se Young Chong
Binex Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1019980044340A external-priority patent/KR20000026684A/ko
Priority claimed from KR1019980044339A external-priority patent/KR20000026683A/ko
Application filed by Se Young Chong, Binex Co Ltd filed Critical Se Young Chong
Application granted granted Critical
Publication of ATE268175T1 publication Critical patent/ATE268175T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
AT99951229T 1998-10-22 1999-10-21 Decursin-enthaltende pharmazeutische zusammensetzungen ATE268175T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1019980044340A KR20000026684A (ko) 1998-10-22 1998-10-22 데커신을 유효성분으로 포함하는 암세포 분화유도제 조성물
KR1019980044339A KR20000026683A (ko) 1998-10-22 1998-10-22 신장독성 억제성분으로서 데커신을 포함하는의약조성물
PCT/KR1999/000632 WO2000023074A1 (en) 1998-10-22 1999-10-21 Pharmaceutical composition containing decursin

Publications (1)

Publication Number Publication Date
ATE268175T1 true ATE268175T1 (de) 2004-06-15

Family

ID=26634241

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99951229T ATE268175T1 (de) 1998-10-22 1999-10-21 Decursin-enthaltende pharmazeutische zusammensetzungen

Country Status (9)

Country Link
US (1) US6525089B1 (de)
EP (1) EP1123097B1 (de)
JP (1) JP4153663B2 (de)
KR (1) KR100504405B1 (de)
AT (1) ATE268175T1 (de)
AU (1) AU767663B2 (de)
CA (1) CA2347750C (de)
DE (1) DE69917796T2 (de)
WO (1) WO2000023074A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100397950B1 (ko) * 2000-01-24 2003-09-19 주식회사 겟웰바이오 데커시놀 또는 이의 유도체를 포함하는 진통제 조성물
KR100385092B1 (ko) * 2000-06-27 2003-05-22 학교법인 인하학원 참당귀로부터 뿌리배양을 이용하여 항암활성 물질데커시놀 안젤레이트를 생산하기 위한 배양, 추출 및분석방법
KR100461585B1 (ko) * 2001-07-24 2004-12-13 학교법인고려중앙학원 데커신 유도체
PL370867A1 (en) * 2001-09-24 2005-05-30 Tosk, Inc. Reduced toxicity cisplatin formulations and methods for using the same
US7115655B2 (en) 2002-04-09 2006-10-03 Elcom Biotechnology, Co. Ltd. Pyranocoumarin derivatives
KR101072175B1 (ko) * 2004-06-22 2011-10-10 최백희 데커신 및/또는 데커시놀 안젤레이트, 또는 데커신및/또는 데커시놀 안젤레이트를 유효성분으로 하는당귀추출물을 포함하는 배뇨장애 치료제 및 부종 치료제조성물
KR100716768B1 (ko) 2005-09-26 2007-05-14 우석대학교 산학협력단 데쿠르신을 유효성분으로 하는 부정맥의 예방 및 치료용조성물, 및 그 제조방법
KR100837733B1 (ko) * 2007-02-22 2008-06-13 김주환 데쿠르신 유도체를 포함하는 아토피성 피부염 질환의 치료및 예방용 조성물
KR100893779B1 (ko) * 2007-05-10 2009-04-20 인제대학교 산학협력단 유해 활성산소 소거효과가 있는 참당귀 추출물의 추출방법
KR20100009295A (ko) * 2008-07-18 2010-01-27 경북대학교 산학협력단 디커신 또는 디커시놀 안젤레이트를 함유한 ｖｅｇｆ에의해 유도된 신생혈관형성 관련 질환의 치료용 조성물
KR101265872B1 (ko) * 2012-11-30 2013-05-22 순천대학교 산학협력단 프래럽토린 a 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 골다공증 예방 또는 치료용 약학적 조성물
EP3019243A4 (de) 2013-07-12 2017-03-15 Ophthotech Corporation Verfahren zur behandlung oder prävention von augenerkrankungen
KR20150040198A (ko) * 2013-10-04 2015-04-14 경성대학교 산학협력단 참당귀 추출물을 유효성분으로 하는 백혈구 감소방지 및 백혈구 회복에 효과를 보이는 약학조성물
KR101658350B1 (ko) 2015-02-06 2016-09-30 경성대학교 산학협력단 고지혈증 치료에 유용한 약학 조성물

Also Published As

Publication number Publication date
JP4153663B2 (ja) 2008-09-24
AU6370399A (en) 2000-05-08
KR100504405B1 (ko) 2005-07-29
EP1123097B1 (de) 2004-06-02
JP2002527476A (ja) 2002-08-27
KR20010080265A (ko) 2001-08-22
CA2347750A1 (en) 2000-04-27
WO2000023074A1 (en) 2000-04-27
US6525089B1 (en) 2003-02-25
DE69917796D1 (de) 2004-07-08
CA2347750C (en) 2008-01-08
EP1123097A1 (de) 2001-08-16
AU767663B2 (en) 2003-11-20
DE69917796T2 (de) 2005-06-09

Similar Documents

Publication Publication Date Title
DK1157037T3 (da) GCSF-konjugater
BR0212921A (pt) Composição farmacêutica com base em fondant
ATE242783T1 (de) Glycopeptid-derivate und pharmazeutische zusammensetzungen, die sie enthalten
GEP20032999B (en) 1-Heterocycle Substituted Diarylamines
DE60045528D1 (de) Pharmazeutische zusammensetzungen, die ccr5-antagonisierende piperazinderivate enthalten
FR2775596B1 (fr) Nouvelles compositions pharmaceutiques
IL154888A0 (en) Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
ZA200206905B (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same.
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
MEP39108A (en) Pharmaceutical composition
TR200003787A3 (tr) Kararli yavas salimli oral dozaj bilesimi.
DE69917796D1 (de) Decursin-enthaltende pharmazeutische zusammensetzungen
DE10084671T1 (de) Pharmazeutische Zusammensetzungen
TR200100054T2 (tr) Paroksetin metansülfonat
BR9810495A (pt) Composição farmacêutica
PT1121127E (pt) Composicoes farmaceuticas orais contendo buprenorfina
DE60019334D1 (de) Antivirale arznei
BR0015256A (pt) Composições farmacêuticas contendo uma droga de antibiótico de fluoroquinolona e uma goma de xantano
HUP0400832A3 (en) New amidoalkyl-piperidine and amidoalkyl-piperazine derivatives, and pharmaceutical compositions containing such derivatives as active ingredients
DE69900561D1 (de) Pharmazeutische Zusammensetzungen enthaltend Mupirocin
UY26171A1 (es) Método y formulación farmacéutica para el tratamiento de la discinesia de aparición tardía
ES2150404T3 (es) Composiciones farmaceuticas de tizoxanida y nitozoxanida.
BR9802803A (pt) ação e composições farmacêuticas contendo os mesmos.
HUP0303379A3 (en) Acid-sensitive compounds, use thereof and pharmaceutical compositions containing them
MA26604A1 (fr) Compositions pharmaceutiques.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties